AstraZeneca signs deal to acquire Icosavax Inc. for $1.1 billion
LONDON, UK: AstraZeneca has entered into a definitive agreement to acquire Icosavax Inc. (NASDAQ: ICVX), a US-based clinical-stage biopharmaceutical company focused on developing differentiated, high-potential...
BerGenBio appoints Anders Tullgren as Chairman of Board
BERGEN, NORWAY: BerGenBio ASA, a clinical-stage biopharmaceutical company, announced today the appointment of Anders Tullgren to succeed Sveinung Hole as Chairman of the Board of...
Inventia sells $30mn worth of American Depositary Shares
PARIS, FRANCE: Inventiva, a clinical-stage biopharmaceutical company, has completed sales of 2.083 million American Depositary Shares (ADS) pursuant to the company’s ATM program established on...
Spectrum Pharmaceuticals announces proposed public offering of common stock
HENDERSON: Spectrum Pharmaceuticals Inc. intends to offer and sell shares of its common stock in an underwritten registered public offering, a news release said. All...